C

Cambridge Epigenetix

76 employees

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

Basic info

Industry

biotechnology research

Sectors

Biomarker discovery
Biotechnology
Health Diagnostics
Health Care
Diagnostic assays
Precision medicine
Epigenetics
Medical
Hydroxymethylation
Methylation
Sequencing

Date founded

2012

Funding rounds raised

Total raised

$88M

from 15 investors over 15 rounds

C

Cambridge Epigenetix raised $88M on November 2, 2021

Investors: Third Point LLC, Temasek, Ahren Innovation Capital, - and GV

C

Cambridge Epigenetix raised $30M on September 3, 2018

Investors: DNA Capital, GV, Ahren Innovation Capital and -

C

Cambridge Epigenetix raised $21M on March 14, 2016

Investors: -, Syncona Limited and GV

C

Cambridge Epigenetix raised $5.5M on October 29, 2014

Investors: Syncona Limited, Cambridge Enterprise and -

FAQ